 |
 |

Intravitreal Antivirals in the Management of Patients With Acquired Immunodeficiency Syndrome With Progressive Outer Retinal Necrosis
Arch Ophthalmol. 2002;120:1219-1222.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Retinal infection with herpes varicella zoster in patients with acquired
immunodeficiency syndrome (AIDS) usually produces multifocal outer retinal
whitening that rapidly progresses to confluent, full-thickness retinal necrosis.
This form of necrotizing herpetic retinopathy, known as progressive outer
retinal necrosis, differs from acute retinal necrosis syndrome principally
in the lack of prominent intraocular inflammation.1
Treatment with intravenous antiviral therapy alone has been associated with
a disappointing visual prognosis.2 We report
the visual outcomes associated with the use of combination systemic and intravitreal
antivirals in the management of 7 patients with AIDS with progressive outer
retinal necrosis.
Report of Cases
There were 4 men and 3 women with AIDS (mean age, 34.6 years [range,
27-38 years]) (Table 1). Two of
the 7 patients had a history of cutaneous varicella-zoster virus infection
and 1 had encephalitis. Six of 7 patients had bilateral involvement at the
time of the diagnosis of retinitis, and the remaining . . . [Full Text of this Article] Comment
Corresponding author and reprints: Janet L. Davis, MD, Bascom Palmer
Eye Institute, PO Box 016880, Miami, FL 33101.
|